| Schedule of Amounts Charged or Credited to the Consolidated Statements of Operations |
Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 were as follows: | | | | | | | | | | | | | Year ended December 31, | | | 2025 | 2024 | 2023 | | (in thousands) | | Amounts charged / (credited) | $ | 39,311 | | $ | (18,085) | | $ | 12,916 | |
|
| Schedule of Estimated Useful Lives of Intangible Assets Amortized on Straight-Line Basis |
Intangible assets are amortized on a straight-line basis over their estimated useful lives, as set forth in the table below:
| | | | | | | Estimated Useful Life | | Customer relationships | 8 - 23 years | | Order backlog | 3 - 5 years | | Trade names | 3 years | | Patient database | 7 years | | Technology assets | 5 years |
The carrying amount of intangible assets for the years ended December 31, 2025, 2024, and 2023 is as follows: | | | | | | | | | | | | | December 31, 2025 | December 31, 2024 | December 31, 2023 | | (in thousands) | | Customer relationships | $ | 4,134,478 | | $ | 4,129,501 | | $ | 4,090,393 | | | Order backlog | 546,054 | | 543,933 | | 541,302 | | | Trade names & brands | 204,721 | | 204,588 | | 204,653 | | | Patient database | 170,511 | | 170,324 | | 170,366 | | | Technology assets | 151,754 | | 150,658 | | 141,257 | | | Total cost | 5,207,518 | | 5,199,004 | | 5,147,971 | | | Accumulated amortization | (1,873,663) | | (1,639,212) | | (1,292,106) | | | Impairment | (86,737) | | — | | — | | | Net book value | $ | 3,247,118 | | $ | 3,559,792 | | $ | 3,855,865 | |
|